Archivos de etiquetas: corazón

Tres en uno ‘polipíldora’ reduce el riesgo de muerte cardíaca en un TERCERO, estudios muestran

A THREE-in-one “polypill” slashes the risk of heart death by a third, estudios muestran.

Experts claim the tabletscontaining aspirin, a statin and a drug which lowers blood pressurecould help millions live longer.

A three-in-one 'polypill' slashes the risk of heart death by a third, estudios muestran

A three-in-one ‘polypillslashes the risk of heart death by a third, estudios muestranCrédito: Alamy

Currently less than half of patients take all their medication after having a heart attack, raising their risk of another event.

But medics found people are much more likely to adhere if they only have a single daily polypill, instead of a cocktail of drugs.

Como resultado, cardiac death risk fell by 33 per cent in trials.

The “striking” findings were presented at the European Society of Cardiology’s annual congress [must keep] en Barcelona.

Experts claim the 50p-a-day polypill should now become routine treatment for Brits after a cardiac event.

Alrededor 100,000 people a year are admitted to hospital after a heart attack in the UK.

Lead scientist Dr Valentin Fuster, head of España’s National Centre for Cardiovascular Research, said he has “great hopes” the polypill will save thousands of lives.

Él dijo: “I am excited because the problem we have in cardiovascular health is that people do not adhere [to drugs]. We know that low adherence has worse outcomes.

“Our study found the adherence to the polypill was significantly better than the pills taken separately. Use of a polypill strategy is safe.

“The results are striking. The polypill group had less heart attacks, stroke and cardiovascular death.”

The study involved 2,500 patients with an average age of 76 who had suffered a heart attack in the previous six months.

Half were given a polypill containing three drugsa dose of aspirin, the blood pressure drug ramipril, y el cholesterol-lowering drug atorvastatin.

The other half were given usual care, which involves multiple separate drugs.

After three years, those on the polypill had a 33 per cent lower risk of heart death.